維他奶(00345.HK)週一大跌日獲主要股東三菱日聯斥逾1億元增持
據聯交所權益披露資料,維他奶國際(00345.HK)於本週一(5日)獲主要股東日本三菱日聯金融集團以每股平均價25.7969元增持409.8萬股,不計手續費涉近1.06億元,所持權益由15.91%增至16.29%。
上週五(7月2日),網傳一份維他奶國際內部文件稱,上週四(7月1日)晚香港襲警事件男子屬該公司員工,文中稱其爲不幸逝世,言辭引發爭議。維他奶在內地的代言人龔俊、任嘉倫先後終止與「維他奶」品牌的一切合作。隨後,有傳公司人力資源總監離職。
7月5日該股股價一度挫近15%,低見25元創逾一年低,挫11.7%,收報25.95元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.